Immediate Impact
54 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Structural characterizations and antiaging activities of hydrolyzed low-molecular-weight polysaccharides from Polygoni Multiflori Radix Praeparata
2025 Standout
Works of Yu‐Ching Lee being referenced
Astragalus membranaceus–Derived Anti‐Programmed Death‐1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors
2020
Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yu‐Ching Lee | 371 | 168 | 80 | 144 | 43 | 775 | |
| Tae Kwun Ha | 213 | 65 | 78 | 63 | 54 | 892 | |
| H. G. Schwick | 337 | 130 | 50 | 71 | 44 | 826 | |
| Nematollah Gheibi | 395 | 24 | 59 | 187 | 94 | 853 | |
| Nagarajan Raju | 552 | 76 | 35 | 35 | 38 | 855 | |
| Wenbin Zhao | 348 | 100 | 142 | 72 | 57 | 754 | |
| Ping Liu | 309 | 156 | 33 | 38 | 31 | 987 | |
| Sajib Chakraborty | 508 | 80 | 95 | 25 | 51 | 923 | |
| Michael B. Otteneder | 409 | 207 | 98 | 21 | 33 | 843 | |
| Ju Bao | 507 | 29 | 84 | 75 | 28 | 815 | |
| C. Sudandiradoss | 468 | 28 | 67 | 43 | 57 | 783 |
All Works
Loading papers...